INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 125 filers reported holding INOVIO PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 1.29 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $44,000 | -21.4% | 15,084 | 0.0% | 0.00% | – |
Q1 2019 | $56,000 | -6.7% | 15,084 | 0.0% | 0.00% | – |
Q4 2018 | $60,000 | -28.6% | 15,084 | 0.0% | 0.00% | – |
Q3 2018 | $84,000 | +42.4% | 15,084 | 0.0% | 0.00% | – |
Q2 2018 | $59,000 | -16.9% | 15,084 | 0.0% | 0.00% | – |
Q1 2018 | $71,000 | – | 15,084 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sante Capital Fund, LP | 115,637 | $1,072,000 | 0.44% |
Defender Capital, LLC. | 135,466 | $1,255,000 | 0.42% |
Green Alpha Advisors, LLC | 62,566 | $580,000 | 0.40% |
Harvest Investment Services, LLC | 51,239 | $474,000 | 0.20% |
SEVEN EIGHT CAPITAL, LP | 118,270 | $1,096,000 | 0.15% |
Cedar Brook Financial Partners, LLC | 54,500 | $505,000 | 0.15% |
WASATCH ADVISORS LP | 3,576,706 | $33,156,000 | 0.14% |
Banco BTG Pactual S.A. | 20,000 | $185,000 | 0.12% |
Keystone Financial Group | 60,712 | $563,000 | 0.10% |
Virtus ETF Advisers LLC | 25,105 | $233,000 | 0.10% |